Current results with rhizoxin: the evaluation of a clinical and a basic scientist.
Authors
Fox, Brian WAffiliation
Paterson Institute for Cancer Research, Christie Hospital & Holt Radium Institute, Manchester, U.K.Issue Date
1992-11
Metadata
Show full item recordCitation
Current results with rhizoxin: the evaluation of a clinical and a basic scientist. 1992, 3 (9):707-9 Ann. Oncol.Journal
Annals of OncologyPubMed ID
1450059Type
ArticleLanguage
enISSN
0923-7534Collections
Related articles
- Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.
- Authors: Verweij J, Wanders J, Gil T, Schöffski P, Catimel G, te Velde A, de Mulder PH
- Issue date: 1996 Feb
- Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group.
- Authors: Kaplan S, Hanauske AR, Pavlidis N, Bruntsch U, te Velde A, Wanders J, Heinrich B, Verweij J
- Issue date: 1996 Feb
- Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme.
- Authors: Graham MA, Bissett D, Setanoians A, Hamilton T, Kerr DJ, Henrar R, Kaye SB
- Issue date: 1992 Apr 1
- Phase I and pharmacokinetic study of rhizoxin.
- Authors: Bissett D, Graham MA, Setanoians A, Chadwick GA, Wilson P, Koier I, Henrar R, Schwartsmann G, Cassidy J, Kaye SB
- Issue date: 1992 May 15
- Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.
- Authors: Hanauske AR, Catimel G, Aamdal S, ten Bokkel Huinink W, Paridaens R, Pavlidis N, Kaye SB, te Velde A, Wanders J, Verweij J
- Issue date: 1996 Feb